Streetbeat News

Stock Prices

BA

DFEN

ITA

Boeing Co (NYSE:BA) is set to launch its Starliner spacecraft, developed with NASA, on its first mission with astronauts to the ISS. The mission is crucial for Boeing's future in space exploration and for obtaining NASA's certification for routine crew rotations. Despite past challenges with Starliner, including software and mechanical issues, this launch is a significant step for Boeing, which has seen its stock decline by 8% over the last year. Investors can also engage with Boeing's performance through ETFs like the iShares U.S. Aerospace & Defense ETF (BATS:ITA) and the Direxion Daily Aerospace & Defense Bull 3X Shares (NYSE:DFEN).

Portfolio Pulse from Shivani Kumaresan

May 06, 2024 | 4:17 pm

PARAA

Paramount Global shares are trading higher after reports that Sony and Apollo are considering acquiring the company.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 4:16 pm

W

Wayfair (NYSE:W) has seen a significant uptick in options trading, with a bullish sentiment from big-money traders. Benzinga's options scanner revealed 22 trades, predominantly bullish, focusing on a price band between $25.0 and $85.0. The company, specializing in e-commerce for home goods, has seen its stock price increase by 4.48% to $66.44. Analysts have varying opinions, with target prices ranging from $58 to $79. The next earnings report is expected in 87 days.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 4:16 pm

BKNG

Recent options trading activity indicates a bullish stance on Booking Holdings (NASDAQ:BKNG) by significant investors, with a price target range of $2000 to $4250. The analysis of 40 trades shows a mix of bullish and bearish expectations, but with a higher total trade price for calls over puts. The largest trades observed were all calls, indicating a bullish sentiment. Booking Holdings, the world's largest online travel agency, has seen its stock price decrease by -1.04% to $3540, with analysts giving mixed ratings but an average target price of $3968.8.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 4:16 pm

VRTX

Smart money investors have shown significant interest in Vertex Pharmaceuticals (NASDAQ:VRTX) options, with an unusual volume of trades indicating a mixed sentiment. The trades, split evenly between bullish and bearish, focus on a price range of $380 to $450 for VRTX. Analysts have varying opinions on VRTX, with target prices ranging from $371 to $466. The company's key products include treatments for cystic fibrosis and it's exploring therapies for other serious diseases. VRTX's stock is currently neutral with a slight increase in price.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 4:15 pm

AAPL

BRK

Warren Buffett's Berkshire Hathaway significantly reduced its Apple stake by 22%, selling about 115 million shares. Despite this, Apple announced a $110 billion share repurchase program, leading to a 6% stock rally. Berkshire's cash reserves are expected to exceed $200 billion, with Apple remaining its largest investment. Apple's stock has shown signs of a market turnaround, surpassing its 200-day moving average and the 50% Fibonacci retracement mark.

Portfolio Pulse from Piero Cingari

May 06, 2024 | 4:03 pm

BENF

Beneficient shares are trading lower after a recent gain on Friday, following the announcement that the company regained compliance with the Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 4:02 pm

SBUX

Starbucks Corp (NASDAQ:SBUX) is experiencing a significant sales decline, with a deceleration pace in same-store sales rarely seen outside major economic crises, according to BofA Securities. Analyst Sara Senatore maintains a Buy rating on Starbucks, with a price target of $108, despite the sales slump. The decline is attributed to a social media narrative around Starbucks' position on the Middle East, rather than consumer check fatigue or pricing issues, as Starbucks' pricing remains competitive. The company's Net Promoter Score has also dropped sharply from October to November 2023.

Portfolio Pulse from Priya Nigam

May 06, 2024 | 4:02 pm

GPRE

Green Plains (NASDAQ:GPRE) has been analyzed by 5 analysts, showing a mix of bullish and indifferent sentiments with a slight decrease in the average 12-month price target to $36.6, down 1.4%. The company faces challenges with a -22.06% revenue decline and below industry benchmarks in profitability and financial performance. Analysts have adjusted their ratings and price targets, reflecting recent market conditions and company performance.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 4:01 pm

EXPE

Analyst ratings for Expedia Group (NASDAQ:EXPE) show varied sentiments, with recent updates indicating a general lowering of price targets and ratings. The average 12-month price target is now $146.3, down from $157.44, reflecting a 7.08% decline. Analysts from firms like Barclays, Susquehanna, and JP Morgan have adjusted their ratings and price targets, mostly downward, in response to the company's performance and market conditions. Expedia's financials reveal challenges in revenue growth, net margin, ROE, and ROA, although its debt management appears sound. The company's market capitalization is below the industry average, indicating a smaller scale compared to peers.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 4:01 pm